Oppenheimer & Co’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$446K Buy
+2,367
New +$420K ﹤0.01% 1308
2022
Q4
Sell
-4,921
Closed -$474K 1364
2022
Q3
$474K Buy
+4,921
New +$529K 0.01% 919
2019
Q2
Sell
-2,405
Closed -$209K 1317
2019
Q1
$209K Buy
+2,405
New +$211K 0.01% 1203
2015
Q3
Sell
-5,620
Closed -$351K 1366
2015
Q2
$351K Buy
+5,620
New +$370K 0.01% 1033

Other funds holding CHRW

Oppenheimer & Co's CHRW Position: Q2 2026 in Review

Oppenheimer & Co opened a new position in C.H. Robinson (CHRW) in Q2 2026: 2,367 shares worth $446K. The stake represents ﹤0.01% of the portfolio and ranks #1308 among its holdings. This is a return to the name: Oppenheimer & Co previously reported a position in CHRW as recently as Q3 2022.

Oppenheimer & Co first reported a position in CHRW in Q2 2015 and has held it in 4 quarters since. The position peaked at $474K in Q3 2022. 891 funds tracked by Wall St. Rank hold CHRW as of Q2 2026.

  • Oppenheimer & Co held 2,367 shares of C.H. Robinson worth $446K as of Q2 2026.
  • C.H. Robinson was a new Oppenheimer & Co position in Q2 2026.
  • C.H. Robinson made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1308 holding.
  • Oppenheimer & Co first reported a position in C.H. Robinson in Q2 2015 and has held it in 4 quarters since.
  • Oppenheimer & Co's C.H. Robinson position peaked at $474K in Q3 2022.
  • 891 funds tracked by Wall St. Rank held C.H. Robinson as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.